−485 KRW
−29.37 B KRW
2.17 B KRW
27.35 M
About PRESTIGE BIOLOGICS CO., LTD.
Sector
CEO
Duk-Hoon Hyun
Headquarters
Cheongju-si
Website
Founded
2015
ISIN
KR7334970001
FIGI
BBG00Z1BFDR2
Prestige Biologics Co., Ltd. engages in research, development, and supplying of pharmaceutical products. The company services include contract development, engineering, and manufacturing organization. It specializes in the development and production of both novel biologic agents and biosimilars. The company was founded on June 2, 2015 and is headquartered in Cheongju-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 334970 is 5,090 KRW — it has increased by 10.11% in the past 24 hours. Watch PRESTIGE BIOLOGICS CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PRESTIGE BIOLOGICS CO., LTD. stocks are traded under the ticker 334970.
334970 stock has risen by 9.63% compared to the previous week, the month change is a −10.54% fall, over the last year PRESTIGE BIOLOGICS CO., LTD. has showed a 18.37% increase.
334970 reached its all-time high on Apr 16, 2021 with the price of 21,550 KRW, and its all-time low was 2,790 KRW and was reached on Jan 3, 2023. View more price dynamics on 334970 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
334970 stock is 15.94% volatile and has beta coefficient of 0.59. Track PRESTIGE BIOLOGICS CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is PRESTIGE BIOLOGICS CO., LTD. there?
Today PRESTIGE BIOLOGICS CO., LTD. has the market capitalization of 352.25 B, it has decreased by −8.24% over the last week.
Yes, you can track PRESTIGE BIOLOGICS CO., LTD. financials in yearly and quarterly reports right on TradingView.
334970 net income for the last quarter is −6.52 B KRW, while the quarter before that showed −15.77 B KRW of net income which accounts for 58.67% change. Track more PRESTIGE BIOLOGICS CO., LTD. financial stats to get the full picture.
No, 334970 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 211.00 employees. See our rating of the largest employees — is PRESTIGE BIOLOGICS CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PRESTIGE BIOLOGICS CO., LTD. EBITDA is −35.30 B KRW, and current EBITDA margin is −1.02 K%. See more stats in PRESTIGE BIOLOGICS CO., LTD. financial statements.
Like other stocks, 334970 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRESTIGE BIOLOGICS CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PRESTIGE BIOLOGICS CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PRESTIGE BIOLOGICS CO., LTD. stock shows the sell signal. See more of PRESTIGE BIOLOGICS CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.